Dr. David Kerr, MBChB, DM, FRCP, FRCPE, highlights key data from the 2025 American Diabetes Association (ADA) conference, relevant to diabetic ketoacidosis (DKA) and ketone monitoring technology. Dr Kerr discusses the clinical implications for DKA management and integrating diabetes technology, including continuous ketone monitoring.

Watch this podcast in video format, and download the companion summary slides at https://diabetes-cgm.ime.springerhealthcare.com/ketone-masterclass/video-podcast/.

Earn free CME credits – visit the complete program website at https://diabetes-cgm.ime.springerhealthcare.com/ketone-masterclass/ and check out the CME-accredited activities on integrating ketone and glucose monitoring for optimized diabetes management.

Intended for healthcare professionals only.

Supported by an independent educational grant from Abbott.

© 2025 Springer Healthcare LLC. Springer Health+ IME is part of Springer Nature. All rights reserved.

In the final episode of the gMG disease dialogues series, Dr. Kelly Gwathmey, MD, and Jude Kings, RGN, discuss the importance of multidisciplinary teamwork in improving outcomes for patients with generalized myasthenia gravis (gMG).

To access the other episodes in the gMG disease dialogues series and earn CME credits, visit https://myastheniagravis.ime.springerhealthcare.com/advances-gmg-disease-dialogues-series/. The series features expert discussion on the new and emerging therapies for gMG, practical insights for integrating treatment advances, and the importance of multidisciplinary collaboration to optimize patient care.

Earn free CME credits- visit https://myastheniagravis.ime.springerhealthcare.com/ to check out the complete accredited program on optimizing patient outcomes in gMG.

Intended for healthcare professionals only.

Supported by an independent educational grant from Merck KGaA, Darmstadt, Germany and UCB Inc.

© 2025 Springer Healthcare LLC. Springer Health+ IME is part of Springer Nature. All rights reserved.

In the third episode of the gMG disease dialogues series, Dr. Kelly Gwathmey, MD, and Dr. Sithara Ramdas, MD, discuss the evolving treatment landscape, pediatric-specific treatment considerations, diagnostic vigilance and how to assess and introduce newer therapies into practice, including advances into personalized patient management in generalized myasthenia gravis (gMG).

To access the other episodes in the gMG disease dialogues series and earn CME credits, visit https://myastheniagravis.ime.springerhealthcare.com/advances-gmg-disease-dialogues-series/. The series features expert discussion on the new and emerging therapies for gMG, practical insights for integrating treatment advances, and the importance of multidisciplinary collaboration to optimize patient care.

Earn free CME credits- visit https://myastheniagravis.ime.springerhealthcare.com/ to check out the complete accredited program on optimizing patient outcomes in gMG.

Intended for healthcare professionals only.

Supported by an independent educational grant from Merck KGaA, Darmstadt, Germany and UCB Inc.

© 2025 Springer Healthcare LLC. Springer Health+ IME is part of Springer Nature. All rights reserved.

In the second half of this two-part episode, Dr. Kelly Gwathmey, MD, and Dr. Pushpa Narayanaswami, MD, FAAN, discuss the importance of understanding the evolving therapeutic landscape for gMG. They explore the latest B-cell and T-cell targeted therapies, including monoclonal antibodies, CAR-T cell approaches, and small molecule inhibitors, with insights into clinical trial data, mechanisms of action, and real-world considerations for patient-centered care.

To access the other episodes in the gMG disease dialogues series and earn CME credits, visit https://myastheniagravis.ime.springerhealthcare.com/advances-gmg-disease-dialogues-series/. The series features expert discussion on the new and emerging therapies for gMG, practical insights for integrating treatment advances, and the importance of multidisciplinary collaboration to optimize patient care.

Earn free CME credits- visit https://myastheniagravis.ime.springerhealthcare.com/ to check out the complete accredited program on optimizing patient outcomes in gMG.

Intended for healthcare professionals only.

Supported by an independent educational grant from Merck KGaA, Darmstadt, Germany and UCB Inc.

© 2025 Springer Healthcare LLC. Springer Health+ IME is part of Springer Nature. All rights reserved.

In the first half of this two-part episode, Dr. Kelly Gwathmey, MD, and Dr. Pushpa Narayanaswami, MD, FAAN, first discuss the evolving landscape of generalized myasthenia gravis (gMG) treatment, including the foundational role of conventional immunotherapies and the emergence of novel agents like FcRn receptor antagonists and complement inhibitors. Learn about the mechanisms, clinical trial data, and practical considerations for integrating these therapies into patient care.

To access the other episodes in the gMG disease dialogues series and earn CME credits, visit https://myastheniagravis.ime.springerhealthcare.com/advances-gmg-disease-dialogues-series/. The series features expert discussion on the new and emerging therapies for gMG, practical insights for integrating treatment advances, and the importance of multidisciplinary collaboration to optimize patient care.

Earn free CME credits- visit https://myastheniagravis.ime.springerhealthcare.com/ to check out the complete accredited program on optimizing patient outcomes in gMG.

Intended for healthcare professionals only.

Supported by an independent educational grant from Merck KGaA, Darmstadt, Germany and UCB Inc.

© 2025 Springer Healthcare LLC. Springer Health+ IME is part of Springer Nature. All rights reserved.

In this episode Prof. Amer Zeidan, MBBS, MHS, and Prof. Courtney D. DiNardo,MD, MSCE, discuss mechanisms of action, efficacy, and safety profiles of novel targeted therapies for IDH1-mutant relapsed/refractory acute myeloid leukemia (R/R AML​).

To access the video-based podcast episode, and learn more about the full series on molecular testing and targeted treatments for improved patient outcomes in R/R AML, visit https://springermedicine.com/aml-expert-series-overview/50892434

Intended for healthcare professionals only.

Supported by an independent educational grant from Rigel.

© 2025 Springer Healthcare LLC. Springer Health+ IME is part of Springer Nature. All rights reserved.

In this first episode of the “gMG disease dialogues” series, host Dr. Kelly Gwathmey, MD, and guest speaker Dr. Sithara Ramdas, MD, discuss adult and pediatric generalized myasthenia gravis (gMG), specifically:

To access the other episodes in the gMG disease dialogues series and earn CME credits, visit https://myastheniagravis.ime.springerhealthcare.com/advances-gmg-disease-dialogues-series/. The series features expert discussion on the new and emerging therapies for gMG, practical insights for integrating treatment advances, and the importance of multidisciplinary collaboration to optimize patient care.

Earn free CME credits- visit https://myastheniagravis.ime.springerhealthcare.com/ to check out the complete accredited program on optimizing patient outcomes in gMG.

Intended for healthcare professionals only.

Supported by an independent educational grant from Merck KGaA, Darmstadt, Germany and UCB Inc.

© 2025 Springer Healthcare LLC. Springer Health+ IME is part of Springer Nature. All rights reserved.

In this patient-physician conversation, Janel Worcester-Brown and Dr. Kelly Gwathmey, MD, engage in compelling and candid discussion of the realities of living with generalized myasthenia gravis (gMG) and the challenges patients face navigating their healthcare journey.

Together, they reveal real-world patient perspectives combined with expert provider insights, to uncover the lived experiences of patients with generalized myasthenia gravis (gMG), the unmet needs and gaps in care, and how embracing a patient-centric approach and shared decision-making can make a difference.

To access the interactive video-based module and learn more about the full, free accredited program on optimizing patient outcomes in gMG, and claim CME credits, visit https://myastheniagravis.ime.springerhealthcare.com/

Intended for healthcare professionals only.

Supported by an independent educational grant from Merck KGaA, Darmstadt, Germany and UCB Inc.

© 2025 Springer Healthcare LLC. Springer Health+ IME is part of Springer Nature. All rights reserved.

In this episode Prof. Amer Zeidan, MBBS, MHS, and Dr. Eunice Wang, MD, discuss:

To access the video-based podcast episode, and learn more about the full series on molecular testing and targeted treatments for improved patient outcomes in R/R AML, visit https://springermedicine.com/aml-expert-series-overview/50892434

Intended for healthcare professionals only.

Supported by an independent educational grant from Rigel.

© 2025 Springer Healthcare LLC. Springer Health+ IME is part of Springer Nature. All rights reserved.

In this episode Prof. Amer Zeidan, MBBS, MHS, and Dr. Sanam Loghavi, MD, discuss:

To access the video-based podcast episode, and learn more about the full series on molecular testing and targeted treatments for improved patient outcomes in R/R AML, visit https://springermedicine.com/aml-expert-series-overview/50892434

Intended for healthcare professionals only.

Supported by an independent educational grant from Rigel.

© 2025 Springer Healthcare LLC. Springer Health+ IME is part of Springer Nature. All rights reserved.